Your browser doesn't support javascript.
loading
Bis-Heteroaryl Pyrazoles: Identification of Orally Bioavailable Inhibitors of Activin Receptor-Like Kinase-2 (R206H).
Sekimata, Katsuhiko; Sato, Tomohiro; Sakai, Naoki; Watanabe, Hisami; Mishima-Tsumagari, Chiemi; Taguri, Tomonori; Matsumoto, Takehisa; Fujii, Yoshifumi; Handa, Noriko; Honma, Teruki; Tanaka, Akiko; Shirouzu, Mikako; Yokoyama, Shigeyuki; Miyazono, Kohei; Hashizume, Yoshinobu; Koyama, Hiroo.
Afiliación
  • Sekimata K; Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science.
  • Sato T; Drug Discovery Computational Chemistry Platform Unit, RIKEN Center for Biosystems Dynamics Research.
  • Sakai N; Drug Discovery Structural Biology Platform Unit, RIKEN Biosystems Dynamics Research.
  • Watanabe H; Drug Discovery Structural Biology Platform Unit, RIKEN Biosystems Dynamics Research.
  • Mishima-Tsumagari C; Drug Discovery Structural Biology Platform Unit, RIKEN Biosystems Dynamics Research.
  • Taguri T; Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science.
  • Matsumoto T; Drug Discovery Structural Biology Platform Unit, RIKEN Biosystems Dynamics Research.
  • Fujii Y; Crystallographic Drug Discovery Platform Unit, RIKEN Systems and Structural Biology Center.
  • Handa N; Crystallographic Drug Discovery Platform Unit, RIKEN Systems and Structural Biology Center.
  • Honma T; Drug Discovery Computational Chemistry Platform Unit, RIKEN Center for Biosystems Dynamics Research.
  • Tanaka A; Drug Discovery Structural Biology Platform Unit, RIKEN Biosystems Dynamics Research.
  • Shirouzu M; Drug Discovery Structural Biology Platform Unit, RIKEN Biosystems Dynamics Research.
  • Yokoyama S; Crystallographic Drug Discovery Platform Unit, RIKEN Systems and Structural Biology Center.
  • Miyazono K; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo.
  • Hashizume Y; RIKEN Program for Drug Discovery and Medical Technology Platforms.
  • Koyama H; Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science.
Chem Pharm Bull (Tokyo) ; 67(3): 224-235, 2019.
Article en En | MEDLINE | ID: mdl-30828000
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Receptores de Activinas Tipo I / Inhibidores de Proteínas Quinasas Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Receptores de Activinas Tipo I / Inhibidores de Proteínas Quinasas Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2019 Tipo del documento: Article